These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 469256)

  • 1. The enzymatic nature of human c1r: a subcomponent of the first component of complement.
    Andrews JM; Baillie RD
    J Immunol; 1979 Sep; 123(3):1403-8. PubMed ID: 469256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of C1 esterase inhibitor in the activation of C1r, a subcomponent of the first component of complement from human plasma.
    Tamura Y; Okamura K; Otsuka A; Fujii S
    J Biochem; 1976 Feb; 79(2):313-9. PubMed ID: 1270407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first component of complement. I. Purification and properties of native C1.
    Medicus RG; Chapuis RM
    J Immunol; 1980 Jul; 125(1):390-5. PubMed ID: 7381205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unconjugated bilirubin inhibits C1 esterase activity.
    Arriaga SM; Basiglio CL; Mottino AD; Almará AM
    Clin Biochem; 2009 Jun; 42(9):919-21. PubMed ID: 19150444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study.
    De Simone G; Balliano G; Milla P; Gallina C; Giordano C; Tarricone C; Rizzi M; Bolognesi M; Ascenzi P
    J Mol Biol; 1997 Jun; 269(4):558-69. PubMed ID: 9217260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.
    Sim RB; Porter RR; Reid KB; Gigli I
    Biochem J; 1977 May; 163(2):219-27. PubMed ID: 869924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical and functional characterization of the C1r subunit of the first complement component.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):496-503. PubMed ID: 814163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
    Siegel RC; Schumaker VN; Poon PH
    J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
    Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
    J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Structure of the active center of subtilisin 72].
    Kazanskaia NF; Kost OA
    Biokhimiia; 1982 May; 47(5):834-41. PubMed ID: 7046815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.
    Arlaud GJ; Villiers CL; Chesne S; Colomb MG
    Biochim Biophys Acta; 1980 Nov; 616(1):116-29. PubMed ID: 6254570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive colorimetric method for the measurement of serum C1 inactivator using the substrate N-alpha-acetyl-L-lysine methyl ester.
    Harpel PC
    J Immunol; 1970 Apr; 104(4):1024-30. PubMed ID: 5429516
    [No Abstract]   [Full Text] [Related]  

  • 13. Inorganic supports coated with N-substituted polyacrylamides: application to biospecific chromatography of proteins.
    Ivanov AE; Kozlov LV; Shojbonov BB; Zubov VP; Antonov VK
    Biomed Chromatogr; 1991 Mar; 5(2):90-3. PubMed ID: 1868265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human C1r: Western blot analysis reveals slow and dose-dependent activation.
    Hosoi S; Borsos T
    J Immunol; 1988 Sep; 141(5):1610-4. PubMed ID: 2842400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of C1r by proteolytic cleavage.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and initial characterization of tumoricidal monokine(s) from the human monocytic leukemia cell line THP-1.
    Armstrong CA; Klostergaard J; Granger GA
    J Natl Cancer Inst; 1985 Jan; 74(1):1-9. PubMed ID: 3918210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on the identification of the subcomponents of the first component of complement after affinity chromatography of human serum on IgG-sepharose.
    Taylor PA; Fink S; Bing DH; Painter RH
    J Immunol; 1977 May; 118(5):1722-7. PubMed ID: 858917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic peculiarities of human tissue kallikrein: 1--substrate activation in the catalyzed hydrolysis of H-D-valyl-L-leucyl-L-arginine 4-nitroanilide and H-D-valyl-L-leucyl-L-lysine 4-nitroanilide; 2--substrate inhibition in the catalyzed hydrolysis of N alpha-p-tosyl-L-arginine methyl ester.
    Sousa MO; Miranda TL; Maia CN; Bittar ER; Santoro MM; Figueiredo AF
    Arch Biochem Biophys; 2002 Apr; 400(1):7-14. PubMed ID: 11913965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C1 subcomponent complexes: basic and clinical aspects.
    Laurell AB; Sjöholm AG
    Behring Inst Mitt; 1993 Dec; (93):292-8. PubMed ID: 8172579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.